Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Loy

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Liver Disease|March 8, 2021
Spotlight on Impactful Research: Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Intermediate-Risk Liver Transplantation RecipientsVeronica Loy
Gastroenterology & Hepatology|February 2, 2026
Insights Into Liver Transplant DisparitiesVeronica Loy
Clinical Liver Disease|July 19, 2019
Myth: Liver Transplant Provides a Cure for Liver DiseaseAdam VanHuis, Veronica Loy
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|October 29, 2014
Performance Feedback Improves Compliance With Quality MeasuresVeronica Loy, James Kwiatt, Amar Dodda, et al.
Antiviral Therapy|July 15, 2016
The time and cost investment required to obtain and initiate direct-acting antiviral therapyVeronica Loy, Tamara Benyashvili, William Adams, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 30, 2013
Physical activity and metabolic syndrome in liver transplant recipientsEric R Kallwitz, Veronica Loy, Praveen Mettu, et al.
Transplantation Proceedings|April 13, 2021
Post-Covid-19 Cholangiopathy-A New Indication for Liver Transplantation: A Case ReportFrancisco A Durazo, Allyssa A Nicholas, Jennifer J Mahaffey, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Liver Disease|March 8, 2021
Spotlight on Impactful Research: Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Intermediate-Risk Liver Transplantation RecipientsVeronica Loy
Gastroenterology & Hepatology|February 2, 2026
Insights Into Liver Transplant DisparitiesVeronica Loy
Clinical Liver Disease|July 19, 2019
Myth: Liver Transplant Provides a Cure for Liver DiseaseAdam VanHuis, Veronica Loy
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|October 29, 2014
Performance Feedback Improves Compliance With Quality MeasuresVeronica Loy, James Kwiatt, Amar Dodda, et al.
Antiviral Therapy|July 15, 2016
The time and cost investment required to obtain and initiate direct-acting antiviral therapyVeronica Loy, Tamara Benyashvili, William Adams, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 30, 2013
Physical activity and metabolic syndrome in liver transplant recipientsEric R Kallwitz, Veronica Loy, Praveen Mettu, et al.
Transplantation Proceedings|April 13, 2021
Post-Covid-19 Cholangiopathy-A New Indication for Liver Transplantation: A Case ReportFrancisco A Durazo, Allyssa A Nicholas, Jennifer J Mahaffey, et al.
Pageof 1